Category: Company

Abselion Welcomes Anne Jones as Non-Executive Director

Abselion Welcomes Anne Jones as Non-Executive Director

Abselion is delighted to announce the appointment of Dr Anne Jones to the board of the company as non-executive director. Anne brings over 25 years of global commercial experience in the Life Sciences, Healthcare and Cell Therapy arenas working with world class...

Meet Abselion

Meet Abselion

The last few years have been nothing short of amazing – together, we have achieved remarkable milestones that we can all be incredibly proud of. From winning countless awards to securing investments, building an exceptional product, and showcasing our outstanding...

A word from our founder

A word from our founder

When Abselion was founded in 2018 (at that time under the name HexagonFab), we did not set out to change the world.

HexagonFab secures £1.9m (USD 2.6m) seed funding to launch the Bolt

HexagonFab secures £1.9m (USD 2.6m) seed funding to launch the Bolt

HexagonFab secures £1.9m (USD 2.6m) seed funding to launch the Bolt, an analytical lab instrument to speed discovery and production of next-generation biopharmaceuticals The Bolt provides convenient and affordable access to molecular binding analytics. ...

Royal Society Awards “Emerging Technology Prize” to HexagonFab

Royal Society Awards “Emerging Technology Prize” to HexagonFab

Chemistry Means Business, a showcase of success and innovation in the sector across the UK and Europe, took place at the Queen Elizabeth II Conference Centre in Westminster on 15 October, complete with sweeping views of the Houses of Parliament and the London Eye.The...